OR ROYALTIES INC
ORNYSETrading Snapshot
- Day Range
- $33.30 β $34.00
- 52-Week Range
- $38.58 β $65.54
- Volume (shares)
- 980,043
- Avg Volume (shares)
- β
- Shares Outstanding
- 186.4M
- Next Earnings
- 2026-11-11
Fundamentals Snapshot
- Annual Revenue
- $282M
- Last Q Revenue
- $98M
- P/E Ratio
- 22.4
- P/S Ratio
- 17.5x
- EPS (TTM)
- $1.50
- Dividend Yield
- 0.61%
- Dilution (1yr)
- +1.4%
OR ROYALTIES INC
ORAbout OR ROYALTIES INC
OR Royalties Inc. specializes in acquiring, developing, and exploring for valuable metals, along with securing various royalty and streaming arrangements. A significant holding for the company is its ownership interest in the Canadian Malartic mine. This firm was established on April 29, 2014, and its primary corporate office is located in Montreal, Canada.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

Osisko Gold Provides Construction Progress Update on the Cariboo Gold Project
(All dollar amounts are expressed in Canadian dollars, unless stated otherwise) HIGHLIGHTS Cariboo Gold Project remains on schedule for anticipated first gold pour in Q1 2029 and commercial production in H2 2029 Project

OR Royalties Inc. $OR Stock Bought by Louisbourg Investments Inc.
Louisbourg Investments Inc. increased its holdings in OR Royalties Inc. (NYSE: OR) by 25.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. Th

Osisko Gold Royalties (TSE:OR) Stock Crosses Above 50 Day Moving Average β Time to Sell?
Shares of Osisko Gold Royalties Ltd (TSE: OR - Get Free Report) crossed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of C$49.47 and traded as high as C$49.98. Osisko Go

Micot Pharma Debuts MT200605 Huntington's Disease Research in a Poster Presentation at MDS 2026 and Expands Development into Neurodegenerative Diseases
HONG KONG, Oct 12, 2026 - (ACN Newswire) - The International Congress of Parkinson's Disease and Movement Disorders (MDS 2026) was held in Seoul, South Korea, f

Osisko Gold: I Tried To Break The Bull Case, And I'm Still Buying
Osisko Gold is building a fully permitted BC gold mine, yet the stock trades below half the value of its reserves alone.Osisko Gold is building a fully permitted BC. I tested five reasons to sell: a cost overrun, thin fu

Is OR Royalties (OR) a Solid Growth Stock? 3 Reasons to Think "Yes"
OR Royalties (OR) possesses solid growth attributes, which could help it handily outperform the market.